Cedars-Sinai experts in pulmonology, critical care medicine and lung transplant attending the May 17-22 American Thoracic Society’s (ATS) 2024 International Conference in San Diego are available to comment on scientific advances being presented throughout the conference.
Tag: interstitial lung disease
PFF Celebrates Black History Month and Encourages Diversity in Research
The PFF celebrates and honors Black History Month this February. The PFF advocates for increasing diversity of patient representation through the PFF Community Registry to enhance research and improve treatment options for those in the African-American and other communities.
Prompt Recognition and Treatment Found Effective for Lung Disease in Patients Who Received New Drug for Advanced Cancer
Lung disease caused by a new drug for cancers—including metastatic or advanced breast cancer—can be effectively treated using approaches that focus on early detection and prompt management, according to a study published in ESMO Open on August 11, 2022.
Post-COVID Lung Disease Shares Origins with Other Scarring Lung Disorders
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
Pulmonary Fibrosis Foundation Research Explores Quality and Access to Patient Care
The Pulmonary Fibrosis Foundation announced research results from four studies examining access to care and outcomes for patients living with pulmonary fibrosis and interstitial lung disease.
Pulmonary Fibrosis Foundation To Launch National Walk Day
The nationwide pulmonary fibrosis (PF) community will take a collective step forward to advance research, advocacy, and awareness in the Pulmonary Fibrosis Foundation’s (PFF) National Walk Day on Saturday, Sept. 25, during Pulmonary Fibrosis Awareness Month.
Focus on “Growing Stronger” for Pulmonary Fibrosis Awareness Month in September
September is Pulmonary Fibrosis Awareness Month, presented by the Pulmonary Fibrosis Foundation (PFF) as a way to drive awareness of pulmonary fibrosis (PF), a debilitating, incurable lung disease. Learn more about the numerous endeavors intended to rejuvenate the fight against PF throughout September.
Lung disease specialist takes up chair named for mentor
Kolb is research director at the Firestone Institute for Respiratory Health at McMaster and St. Joseph’s Healthcare Hamilton, as well as division director for respirology at the Department of Medicine. He is also the European Respiratory Journal’s chief editor.
The Role of Air Pollution in Pulmonary Fibrosis
To mark Clean Air Month, the Pulmonary Fibrosis Foundation (PFF) aims to increase public understanding of the role air pollution has in the development of interstitial lung diseases (ILD) such as pulmonary fibrosis (PF), including how polluted air can make you sick and the telltale signs to be aware of.
Pulmonary Fibrosis Foundation Launches Campaign To Raise PF Awareness And Early Diagnosis
The Pulmonary Fibrosis Foundation today announced the “Pinpoint PF” education and awareness campaign aimed at individuals with symptoms and at a higher risk for pulmonary fibrosis (PF).